PharmaTher, a clinical-stage psychedelics biotech company, announces it has entered into an agreement with Alcami Corporation, a global pharmaceutical contract development and manufacturing organization with extensive experience in cGMP sterile fill-finish products and handling of controlled substances, for the clinical and commercial manufacturing of the company’s proprietary ketamine products.
Compound Ketamine
Visit article
Category Press Release
Companies Featured
PharmaTherPharmather is a Canadian life sciences listed company that is developing psychedelics for brain and nervous system disorders.